1. 3-Azido-3deoxythymidine: BW A509U; an antiviral agent that inhibits the infectivity and cytopathic eVect of human T-lymphotrophic virus type III/lymphadenopathy associated;Mitsuya, H.; Weinhold, K.J.; Furman, P.A.,1985
2. Factfile of current antiviral agentsPart I. Herpesviruses and other viruses;Balzarini, J.; Schinazi, R.F.; Kinchington, D.,1997
3. Factfile of current antiviral agentsPart II. Human immunodeficiency viruses;Kinchington, D.; Balzarini, J.; Field, H.J.;International Antiviral News,1997
4. Multiple mutations in HIV-1 transcriptase confer high level resistance to zidovudine (AZT);Larder, B.A.; Kemp, S.D.;Science,1989
5. Delta Co-ordinating Committee. Delta: a randomised double blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals;Lancet,1996